Fixed Dose of Cemiplimab in Patients with Advanced Malignancies based on Population Pharmacokinetic Analysis
Version 2 2021-03-04, 17:38
Version 1 2021-03-04, 17:36
figure
posted on 2021-03-04, 17:38 authored by Adis journals on behalf of, Anne J. Paccaly, Michael R. Migden, Kyriakos P. Papadopoulos, Feng Yang, John D. Davis, Ronda K. Rippley, Israel Lowy, Matthew G. Fury, Elizabeth Stankevich, Danny Rischin<p> <strong>Article full
text</strong></p>
<p><br></p><p>
The above summary slide represents the opinions of
the authors. For a full list of declarations, including funding and author
disclosure statements, please see the full text online (see “read the
peer-reviewed publication” opposite). </p>
<p>© The authors, CC-BY-NC 2021.</p>
<p><b> </b></p>
History
Related Materials
- 1.
- 2.
